Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 10 matching records.
10 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Plant-derived extracellular vesicles as tools and targets for inflammatory diseases
Narrative Review on Chronic Inflammation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
- 2026
J Nanobiotechnology4 citations - Level DNarrative ReviewPubMed
Extracellular Vesicles in Obesity: From Pathophysiological Mediators to Therapeutic Tools.
Narrative Review on Type 2 Diabetes, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Extracellular vesicles in cardiovascular diseases: pathogenic mediators, diagnostic tools, and therapeutic vectors
Narrative Review on Cardiovascular Disease, Stroke Research, published in Front Cardiovasc Med (2025) — summary generated from the PubMed abstract.
- 2025
Front Cardiovasc Med - Level DNarrative ReviewEurope PMC
Extracellular vesicles as tools and targets in therapy for diseases
Narrative Review on Neuroinflammation, Autoimmune Research, published in Signal Transduct Target Ther (2024) — summary generated from the PubMed abstract.
- 2024
Signal Transduct Target Ther826 citations - Level DNarrative ReviewPubMed
Mesenchymal stem cells and their extracellular vesicles as emerging therapeutic tools in the treatment of ischemic stroke.
Narrative Review on Stroke Research, Immune Modulation, published in Tissue Cell (2024) — summary generated from the PubMed abstract.
- 2024
Tissue Cell - Level DNarrative ReviewEurope PMC
Tools for regulating metabolic diseases: extracellular vesicles from adipose macrophages
Narrative Review on Type 2 Diabetes, published in Front Endocrinol (Lausanne) (2024) — summary generated from the PubMed abstract.
- 2024
Front Endocrinol (Lausanne) - Level DNarrative ReviewEurope PMC
Naïve or Engineered Extracellular Vesicles from Different Cell Sources: Therapeutic Tools for Kidney Diseases
Narrative Review on Chronic Kidney Disease, Acute Kidney Injury, published in Pharmaceutics (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceutics14 citations - Level DNarrative ReviewEurope PMC
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles
Narrative Review on Face & Skin, published in Biomark Res (2023) — summary generated from the PubMed abstract.
- 2023
Biomark Res24 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
Narrative Review on Neuroinflammation, published in Cells (2021) — summary generated from the PubMed abstract.
- 2021
Cells33 citations - Level DNarrative ReviewEurope PMC
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools
Narrative Review, published in Cancers (Basel) (2020) — summary generated from the PubMed abstract.
- 2020
Cancers (Basel)28 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406